Restasis and Atacand drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Restasis (cyclosporine) and Atacand (candesartan cilexetil). Common drug interactions include tachycardia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Restasis and Atacand. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

What is Atacand?

Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 22,473 Atacand users. Check the latest studies of Atacand.

On Jul, 23, 2026

40 people who take Restasis and Atacand together, and have interactions are studied.

What are the common drug interactions of Restasis and Atacand, by gender? *:

female:

Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Chronic kidney disease
Dizziness
Gait disturbance
Oedema peripheral (superficial swelling)
Renal failure (kidney dysfunction)
Swelling
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Eye irritation
Heart rate increased

male:

Anaemia (lack of blood)
Eye irritation
Oedema peripheral (superficial swelling)
Pyrexia (fever)

What are the common drug interactions of Restasis and Atacand, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Nausea (feeling of having an urge to vomit)
Neoplasm malignant (cancer tumour)

50-59:

Drug ineffective
Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
Chest pain
Dyspnoea (difficult or laboured respiration)
Foreign body sensation in eyes (feeling of something in eye)
Vulvovaginal mycotic infection (vulvovaginal fungal infection)

60+:

Oedema peripheral (superficial swelling)
Pain in extremity
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Abdominal discomfort
Asthma
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Dry throat
Hearing impaired
Muscle spasms (muscle contraction)
Myalgia (muscle pain)

What are the existing conditions these people have? *

High Blood Cholesterol: 8 people, 20.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 17.50%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 12.50%
Asthma: 4 people, 10.00%
Insomnia (sleeplessness): 4 people, 10.00%
Pain: 3 people, 7.50%
Cardiac Disorder: 3 people, 7.50%
Gastric Ph Decreased: 3 people, 7.50%
Urinary Tract Infection: 2 people, 5.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Restasis and Atacand?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously